SC
ITCI

SouthState Corp’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

SouthState Corp’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-8
Closed -$1.06K – 1851
2025
Q1 		$1.06K Buy
+8
New +$997 ﹤0.01% 1321

Other funds holding ITCI

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
KIM
Kestra Investment Management Austin, Texas $5.8B AUM 14.71% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

SouthState Corp's ITCI Position: Q2 2025 in Review

SouthState Corp sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 8 shares — an estimated $1.06K sold.

SouthState Corp first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $1.06K in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

  • SouthState Corp reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
  • SouthState Corp sold 8 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $1.06K.
  • SouthState Corp first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
  • SouthState Corp's Intra-Cellular Therapies Inc. position peaked at $1.06K in Q1 2025.
  • 4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on SouthState Corp's 13F filing for Q2 2025, filed 6 Aug 2025.